New biotech fund spun out of BDC aims to raise $200-million after string of investment wins in Canada [Toronto Globe and Mail (Ontario, Canada)]
Zymeworks Inc. (ZYME)
Last zymeworks inc. earnings: 3/2 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.zymeworks.com/overview
Company Research
Source: Toronto Globe and Mail
New biotech fund spun out of BDC aims to raise $200-million after string of investment wins in Canada A new Canadian-focused biotech venture fund spun out of Business Development Bank of Canada has raised more than $1-million as it aims to woo reluctant domestic investors to an asset class that has enjoyed one of its strongest years in Canada. Amplitude Venture Capital, led by former BDC fund managers Jean-François Pariseau and Dion Madsen, said it has secured financing from a handful of Quebec institutions that have been Canada’s most active funders of domestic biotech venture capital. They are Teralys Capital, Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ and the Quebec government’s investing arm, Investissement Québec. Now, the pair hopes to reach their $2-million target by convincing other investors in Canada and abroad that there are more opportunities like the string of investment successes they’ve had at BDC. “We want to expand and amplify what we are doing,”
Show less
Read more
Impact Snapshot
Event Time:
ZYME
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYME alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYME alerts
High impacting Zymeworks Inc. news events
Weekly update
A roundup of the hottest topics
ZYME
News
- Buy Zymeworks Pioneering Cancer Treatments: Zanidatamab's Promising Data [Seeking Alpha]Seeking Alpha
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME Accesswire
- ZYME ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Zymeworks Inc.Accesswire
- HER2+ Market to Accelerate Substantially by 2034, Predicts DelveInsight | Key Companies - Zymeworks, Jazz Pharmaceuticals, Ambrx, AnBogen Therapeutics, Enliven Therapeutics, Roche [Yahoo! Finance]Yahoo! Finance
- Levi & Korsinsky Reminds Shareholders of an Investigation into Zymeworks Inc. (ZYME) Regarding Potential Securities Fraud AllegationsAccesswire
ZYME
Earnings
- 3/6/24 - Beat
ZYME
Sec Filings
- 4/4/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 3
- ZYME's page on the SEC website